- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
New emerging visual screening software valid and reliable for diagnosing hemianopia
Thailand: Supharat Jariyakosol and the team's CU-VF new program demonstrates strong validity and reliability in hemianopia detection, quicker time, and more satisfaction of subjects compared to the Standard automated perimeter (SAP). Homonymous hemianopia is caused by lesions of the retro chiasmal visual pathway. In population-based cohort research, the prevalence of homonymous hemianopia was observed to be 0.8 percent.
This study was published in Dovepress- Eye Brain journal on 29th August 2021 and the main objective of this work was to compare the diagnostic accuracy of visual field findings produced by newly created software (CU-VF) with standard automated perimetry (SAP) for diagnosing hemianopia.
The CU-VF software on a personal computer and SAP were used to evaluate 43 patients with hemianopia and 33 controls. Hemianopia was defined as the existence of a hemianopic field on SAP respecting the vertical meridian with the associated neuroimaging pathology as determined by two neuro-ophthalmologists. In terms of the existence of hemianopia, the results of CU-VF were independently reviewed by two neuro-ophthalmologists, one general ophthalmologist, and one general practitioner. For inter-observer reliability, the sensitivity, specificity, and kappa coefficient were determined.
The results of this study demonstrate that the CU-VF test has a relatively high sensitivity (74.42 percent) and specificity (93.94 percent) when SAP is used as the gold standard. The AUC is 0.84, which indicates a satisfactory test. These findings confirm the usefulness of our CU-VF test as a diagnostic and prospective screening test. The CU-VF test was used to assess interobserver agreement. The results reveal that neuro-ophthalmologists and general ophthalmologists have a fair agreement (0.71) and neuro-ophthalmologists and general practitioners have an outstanding agreement (0.84). When compared to the CU-VF test result, CVF has equivalent specificity but lower sensitivity.
In conclusion, this can be used as an additional diagnostic and screening technique in hemianopic individuals. Once it is made public, it has significant potential benefits for clinical practice and the general public in areas where SAP is not widely accessible.
Reference:
Jariyakosol, S., Jaru-ampornpan, P., Manassakorn, A., Itthipanichpong, R., Hirunwiwatkul, P., Tantisevi, V., Somkijrungroj, T., & Rojanapongpun, P. (2021). Sensitivity and Specificity of New Visual Field Screening Software for Diagnosing Hemianopia. Eye and Brain, Volume 13, 231–238. https://doi.org/10.2147/eb.s315403
Medical Dialogues consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751